Of interest, baseline CSF p-tau, NfL, and sTREM2 were significantly higher in PD-MCI patients showing cognitive worsening, which suggests the possibility to consider these CSF biomarkers as prognostic factors. Here, MAPT is linked to Parkinson disease.